With a market cap of $9.5 billion, Baxter International Inc. (BAX) is a global healthcare company that specializes in medical products and therapies, with a strong focus on renal care, medication delivery, and pharmaceuticals. The company provides a wide range of healthcare solutions for hospitals, clinics, and home care settings worldwide. Shares of the Deerfield, Illinois-based company have lagged behind the broader market over the past 52 weeks. BAX stock has decreased 48.5% over this time frame, while ...

Key Takeaways BAX's Q3 revenues are estimated at $2.87B, up 6.4% year over year, with EPS projected at 60 cents.Advanced Surgery, Compounding, and Care & Connectivity likely drove BAX's operational growth.IV fluid conservation, anesthesia weakness, and paused pump shipments may have limited BAX's margins.Baxter International Inc. (BAX) is scheduled to release third-quarter 2025 results on Oct. 30, before the opening bell. In the last reported quarter, the company’s earnings missed the Zacks Consensus Estima ...